A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD

Gregory Feldman,1 François Maltais,2 Sanjeev Khindri,3 Mitra Vahdati-Bolouri,3 Alison Church,4 William A Fahy,3 Roopa Trivedi4,5 1S. Carolina Pharmaceutical Research, Spartanburg, SC, USA; 2Institut universitaire de cardiologie et de pneumologie de Québec, Quebec, QC, Canada;...

Full description

Bibliographic Details
Main Authors: Feldman G, Maltais F, Khindri S, Vahdati-Bolouri M, Church A, Fahy WA, Trivedi R
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:International Journal of COPD
Subjects:
tiotropium
umeclidinium
COPD
non-inferiority
long-acting muscarinic antagonist
Online Access:https://www.dovepress.com/a-randomized-blinded-study-to-evaluate-the-efficacy-and-safety-of-umec-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/a-randomized-blinded-study-to-evaluate-the-efficacy-and-safety-of-umec-peer-reviewed-article-COPD

Similar Items